In Vitro Reactivity of the Glucose Degradation Product 3,4-Dideoxyglucosone-3-ene (3,4-DGE) towards Abundant Components of the Human Blood Circulatory System.

3,4-dideoxyglucosone-3-ene (3,4-DGE) collagen type IV diabetes glucose degradation product glycation human serum albumin immunoglobulin G l-glutathione oxidative stress α,β-unsaturated dicarbonyl

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 Apr 2022
Historique:
received: 03 03 2022
revised: 13 04 2022
accepted: 17 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

3,4-Dideoxyglucosone-3-ene (3,4-DGE) is a glucose degradation product present in processed foods and medicinal products. Additionally, its constant formation from 3-deoxyglucosone in plasma has been suggested. Due to its α,β-unsaturated dicarbonyl moiety, 3,4-DGE is highly reactive and has shown harmful effects in vitro. Here, we investigated the impact of major components of the human blood circulatory system on 3,4-DGE in vitro. Under physiological conditions, plasma concentrations of human serum albumin (HSA) reacted efficiently with 3,4-DGE, resulting in only 8.5% of the initial 3,4-DGE concentration after seven hours (vs. 83.4% without HSA, p < 0.001). Thereby, accessible thiol groups were reduced from 0.121 to 0.064 mol/mol HSA, whereas ketoprofen binding and esterase-like activity of HSA were not affected. Plasma concentrations of glutathione (GSH) reacted immediately and completely with 3,4-DGE, leading to two stereoisomeric adducts. Plasma concentrations of immunoglobulin G (IgG) bound to 3,4-DGE to a lower extent, resulting in 62.6% 3,4-DGE after seven hours (vs. 82.2% in the control, p < 0.01). Immobilized human collagen type IV did not alter 3,4-DGE concentrations. The results indicated that particularly HSA, GSH, and IgG readily scavenge 3,4-DGE after its appearance in the blood stream, which may be associated with a reduced antioxidative and cytoprotective activity for the living cells and, thus, the human organism by blocking free thiol groups.

Identifiants

pubmed: 35562948
pii: ijms23094557
doi: 10.3390/ijms23094557
pmc: PMC9103577
pii:
doi:

Substances chimiques

3,4-dideoxyglucosone-3-ene 0
Immunoglobulin G 0
Pyrones 0
Sulfhydryl Compounds 0
Glutathione GAN16C9B8O
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Biochem J. 1998 Mar 15;330 ( Pt 3):1241-8
pubmed: 9494092
Clin Chim Acta. 1987 Jul 15;166(2-3):143-53
pubmed: 3621595
Nephrol Dial Transplant. 2008 Oct;23(10):3307-15
pubmed: 18524790
Annu Rev Biochem. 1983;52:711-60
pubmed: 6137189
Clin Chem Lab Med. 2014 Jan 1;52(1):85-91
pubmed: 23492564
Anal Chem. 2011 Dec 15;83(24):9660-8
pubmed: 22082450
Kidney Int. 2005 Sep;68(3):1303-11
pubmed: 16105065
Ann N Y Acad Sci. 2005 Jun;1043:111-7
pubmed: 16037229
Biochem J. 2000 Aug 1;349 Pt 3:813-9
pubmed: 10903143
Eur J Biochem. 1980 Mar;104(2):469-78
pubmed: 6244951
Br J Rheumatol. 1998 Dec;37(12):1307-14
pubmed: 9973155
Clin Exp Immunol. 1994 Nov;98(2):245-51
pubmed: 7955529
Chem Pharm Bull (Tokyo). 1979 Nov;27(11):2781-6
pubmed: 527146
Lancet. 2011 Jul 2;378(9785):31-40
pubmed: 21705069
J Pharm Sci. 2011 Jul;100(7):2543-50
pubmed: 21287557
J Biol Chem. 2005 Feb 18;280(7):5724-32
pubmed: 15557329
Anal Biochem. 2003 Jan 15;312(2):224-7
pubmed: 12531209
Perit Dial Int. 2004 Jul-Aug;24(4):392-8
pubmed: 15335155
Arch Biochem Biophys. 1959 May;82(1):70-7
pubmed: 13650640
Biol Mass Spectrom. 1993 Jun;22(6):319-25
pubmed: 8329460
Proc Natl Acad Sci U S A. 1984 Jan;81(2):583-7
pubmed: 6582514
Mol Nutr Food Res. 2005 Jul;49(7):710-5
pubmed: 15915443
J Biol Chem. 2020 May 8;295(19):6330-6343
pubmed: 32198181
Front Immunol. 2014 Oct 20;5:520
pubmed: 25368619
J Agric Food Chem. 2016 Apr 6;64(13):2746-53
pubmed: 26984557
Perit Dial Int. 2008 May-Jun;28(3):277-82
pubmed: 18474921
Intensive Care Med. 2010 Jul;36(7):1213-20
pubmed: 20397009
Biochemistry. 2015 May 19;54(19):3051-62
pubmed: 25915793
Drug Discov Today. 2016 Oct;21(10):1620-1631
pubmed: 27320689
Food Chem. 2021 Mar 1;339:128063
pubmed: 33152865
Br J Pharmacol. 2007 Jul;151(5):580-90
pubmed: 17471184
Chem Res Toxicol. 2014 Aug 18;27(8):1421-30
pubmed: 25033248
Oxid Med Cell Longev. 2021 Aug 8;2021:9912240
pubmed: 34422213
Anal Bioanal Chem. 2012 Jul;403(10):2923-31
pubmed: 22382856
J Immunol Methods. 1982;50(1):51-6
pubmed: 7086149
Cold Spring Harb Perspect Biol. 2011 Jan 01;3(1):a004978
pubmed: 21421911
Anal Bioanal Chem. 2011 Feb;399(4):1689-97
pubmed: 21136045
Nephrol Dial Transplant. 2009 May;24(5):1436-42
pubmed: 19033251
Biochem J. 1990 Jul 1;269(1):1-11
pubmed: 2198020
Chem Res Toxicol. 2019 Feb 18;32(2):304-311
pubmed: 30640474
J Chromatogr B Biomed Sci Appl. 1999 Aug 6;731(1):23-36
pubmed: 10491986
Mol Pharmacol. 1975 Nov;11(6):824-32
pubmed: 1207674
Anal Bioanal Chem. 2011 Sep;401(4):1183-93
pubmed: 21725830
Semin Cancer Biol. 2018 Apr;49:1-8
pubmed: 29174601
Arch Toxicol. 2014 Mar;88(3):597-608
pubmed: 24337777
Clin Chim Acta. 2013 Oct 21;425:64-76
pubmed: 23891854
Angew Chem Int Ed Engl. 2014 Sep 22;53(39):10316-29
pubmed: 25044982
Eur J Clin Nutr. 1997 Apr;51(4):266-72
pubmed: 9104578
J Agric Food Chem. 2009 Nov 25;57(22):10837-44
pubmed: 19874027
J Agric Food Chem. 2013 Oct 30;61(43):10238-45
pubmed: 23452313
Matrix Biol. 1995 Feb;14(6):439-45
pubmed: 7795882

Auteurs

Andrea Auditore (A)

Food Chemistry, Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Nikolaus-Fiebiger-Straße 10, 91058 Erlangen, Germany.

Sabrina Gensberger-Reigl (S)

Food Chemistry, Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Nikolaus-Fiebiger-Straße 10, 91058 Erlangen, Germany.

Monika Pischetsrieder (M)

Food Chemistry, Department of Chemistry and Pharmacy, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Nikolaus-Fiebiger-Straße 10, 91058 Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH